1 – 10 of 164
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2018
- Effects on the glucagon response to hypoglycaemia during DPP-4 inhibition in elderly subjects with type 2 diabetes : A randomized, placebo-controlled study
- DNA methylation in the pathogenesis of type 2 diabetes in humans
- Valuing a Lifestyle Intervention for Middle Eastern Immigrants at Risk of Diabetes
- Intratumoural leukocyte infiltration is a prognostic indicator among pancreatic cancer patients with type 2 diabetes
- Sulforaphane improves disrupted ER-mitochondria interactions and suppresses exaggerated hepatic glucose production
- Impact of a multifactorial treatment programme on clinical outcomes and cardiovascular risk estimates : A retrospective cohort study from a specialised diabetes centre in Denmark
- Defining G protein-coupled receptor peptide ligand expressomes and signalomes in human and mouse islets
- A disease-specific questionnaire for measuring patient-reported outcomes and experiences in the Swedish National Diabetes Register : Development and evaluation of content validity, face validity, and test-retest reliability
- Sugar-sweetened beverage intake associations with fasting glucose and insulin concentrations are not modified by selected genetic variants in a ChREBP-FGF21 pathway : a meta-analysis
- DPP-4 is expressed in human pancreatic beta cells and its direct inhibition improves beta cell function and survival in type 2 diabetes